Suchergebnisse - (Person:"Gökmen-Polar, Yesim")

PubPharm (5)

1

Targeting the Tumor-Tumor Microenvironment Crosstalk

enthalten in: Expert opinion on therapeutic targets | 2023

von Badve, S. | Gökmen-Polar, Y.

2

Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways

enthalten in: EMBO reports | 2019

von Gökmen-Polar, Y. | Neelamraju, Y. | Goswami, C. | +7

3

HSF1 as a Cancer Biomarker and Therapeutic Target

enthalten in: Current cancer drug targets | 2019

von Carpenter, R. | Gökmen-Polar, Y.

4

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models

enthalten in: Breast cancer research and treatment | 2012

von Gökmen-Polar, Y. | Liu, Y. | Toroni, R. | +5

5

Redefining the target again : chemotherapeutics as vascular disrupting agents?

enthalten in: Cancer cell | 2008

von Gokmen-Polar, Y. | Miller, K.

CommentOn: Cancer Cell. 2008 Sep 9;14(3):263-73. - PMID 18772115

1
[1]